A. S. Levin, Assistant Professor of Orthopaedic Surgery, The Johns Hopkins University, Department of Orthopaedic Surgery, Baltimore, MD, USA
Adam S. Levin MD, The Johns Hopkins University, Department of Orthopaedic Surgery, 601 North Caroline Street, Baltimore, MD 21287 USA, Email: email@example.com
This CORR Insights® is a commentary on the article “Should the Use of Biologic Agents in Patients With Renal and Lung Cancer Affect Our Surgical Management of Femoral Metastases?” by Gutowski and colleagues available at: DOI: 10.1097/CORR.0000000000000434.
The author certifies that neither he, nor any members of his immediate family, have any commercial associations (such as consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.
The opinions expressed are those of the writer, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.
Received August 08, 2018
Accepted August 16, 2018